Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Download Data

Alpha Tau Medical Ltd Cash Return on Equity (CROE) for the year ending December 31, 2023: -0.21

Alpha Tau Medical Ltd Cash Return on Equity (CROE) is -0.21 for the year ending December 31, 2023, a 5.94% change year over year. The cash return on equity ratio measures the profitability of a company's shareholders' equity based on its operating cash flow. It is calculated by dividing operating cash flow by shareholders' equity. This ratio provides insight into how effectively the company generates cash flow in relation to the shareholders' investment. A higher ratio indicates better cash flow generation relative to the equity invested.

Alpha Tau Medical Ltd Cash Return on Equity (CROE) for the year ending December 31, 2022 was -0.23, a -166.54% change year over year.
Alpha Tau Medical Ltd Cash Return on Equity (CROE) for the year ending December 31, 2021 was 0.34, a -60.52% change year over year.
Alpha Tau Medical Ltd Cash Return on Equity (CROE) for the year ending December 31, 2020 was 0.86, a -97.60% change year over year.
Alpha Tau Medical Ltd Cash Return on Equity (CROE) for the year ending December 31, 2019 was 35.80.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends